|
|
Volumn 14 Suppl 3, Issue , 2006, Pages
|
|
Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANOREXIGENIC AGENT;
ANTIOBESITY AGENT;
BARIATRIC SURGERY;
BIOLOGICAL MODEL;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG EFFECT;
EXPERIMENTAL THERAPY;
FOOD INTAKE;
HUMAN;
INSTRUMENTATION;
METABOLIC SYNDROME X;
METHODOLOGY;
OBESITY;
PHYSIOLOGY;
REVIEW;
RISK FACTOR;
WEIGHT REDUCTION;
ANTI-OBESITY AGENTS;
APPETITE DEPRESSANTS;
APPETITE REGULATION;
BARIATRIC SURGERY;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
HUMANS;
METABOLIC SYNDROME X;
MODELS, BIOLOGICAL;
OBESITY;
OVERWEIGHT;
RISK FACTORS;
THERAPIES, INVESTIGATIONAL;
WEIGHT LOSS;
|
|
EID: 35648989328
PISSN: 19307381
EISSN: None
Source Type: Journal
DOI: 10.1038/oby.2006.294 Document Type: Review |
|
Times cited : (18)
|
|
References (33)
|
